2/24/2006 11:35:52 AM
Osaka, Feb 24, 2006 (JCN) - Mitsubishi Pharma and Lequio Pharma jointly announced on February 23 that they have signed a licensing agreement with Korean pharmaceutical company Yuhan Corporation. Under the terms of the agreement, Yuhan receives the exclusive right to import and market ZIONE Injection in Korea. Yuhan aims to launch the agent as soon as possible.
comments powered by